AVNS
Big deal, big pop
Avanos Medical just landed in the buyout bucket. The company said it has a definitive agreement to be acquired by affiliates of American Industrial Partners in an all-cash transaction valuing the healthcare company at roughly $1.272 billion.
The cash offer is the whole story
Shareholders are set to receive $25.00 per share in cash, which explains why the stock ripped nearly 70% on the news. In plain English: the market is suddenly pricing in a very real payday, not some vague “strategic alternatives” corporate fog machine.
Why investors care
If the deal closes, Avanos stops being a public stock and becomes a private company in the second half of 2026. That means the upside from here is mostly about the deal getting done, not about the company magically discovering a new growth rocket.
The fine print you shouldn’t ignore
- The transaction still has to clear the usual closing hurdles
- The expected close is in the second half of 2026
- Once it’s done, AVNS shareholders won’t own a public equity anymore
Big picture: this is a classic takeover pop — great if you were already holding the shares, less exciting if you were hoping for a long public-company turnaround story.